• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

过氧化物酶体增殖物激活受体γ(PPARγ)的激活导致人结肠癌细胞非锚定依赖性生长受到抑制。

Activation of PPARgamma leads to inhibition of anchorage-independent growth of human colorectal cancer cells.

作者信息

Brockman J A, Gupta R A, Dubois R N

机构信息

Gastroenterology Division, Departments of Medicine and Cell Biology, Vanderbilt University Medical Center and Veterans Affairs Medical Center, Nashville, Tennessee, USA.

出版信息

Gastroenterology. 1998 Nov;115(5):1049-55. doi: 10.1016/s0016-5085(98)70072-1.

DOI:10.1016/s0016-5085(98)70072-1
PMID:9797355
Abstract

BACKGROUND & AIMS: Peroxisomal proliferator-activated receptor gamma (PPARgamma) is a nuclear hormone receptor that provides a direct link between fatty acid metabolism and control of gene transcription. The objective of this study was to determine the biological effect(s) of PPARgamma activation in colorectal carcinoma cells.

METHODS

PPARgamma expression and activity were measured in 4 human colon cancer cell lines using reverse-transcription polymerase chain reaction, immunoprecipitation and immunoblotting, and transient reporter gene assays. The effects of activated PPARgamma in these cell lines were assessed in cellular proliferation and anchorage-independent growth assays. Flow cytometry was used to determine the effects of PPARgamma activation on progression through the cell cycle.

RESULTS

PPARgamma was expressed in all 4 colon cancer cell lines examined and was transcriptionally functional in 3 of the 4. Treatment of these cells with a selective PPARgamma activator (BRL 49653) resulted in inhibition of anchorage-independent growth. The degree of growth inhibition correlated with the level of functional PPARgamma present. Finally, activation of PPARgamma resulted in G1 cell cycle arrest.

CONCLUSIONS

Activation of the PPARgamma pathway in colon cancer cells has potent antiproliferative effects, suggesting that this nuclear hormone receptor may provide a novel target for prevention and treatment of colorectal cancer in humans.

摘要

背景与目的

过氧化物酶体增殖物激活受体γ(PPARγ)是一种核激素受体,它在脂肪酸代谢与基因转录调控之间建立了直接联系。本研究的目的是确定PPARγ激活在结肠癌细胞中的生物学效应。

方法

使用逆转录聚合酶链反应、免疫沉淀和免疫印迹以及瞬时报告基因分析,在4种人结肠癌细胞系中检测PPARγ的表达和活性。通过细胞增殖和非锚定依赖性生长分析评估激活的PPARγ在这些细胞系中的作用。采用流式细胞术确定PPARγ激活对细胞周期进程的影响。

结果

在所检测的所有4种结肠癌细胞系中均表达PPARγ,并且在其中3种细胞系中具有转录功能。用选择性PPARγ激活剂(BRL 49653)处理这些细胞导致非锚定依赖性生长受到抑制。生长抑制程度与存在的功能性PPARγ水平相关。最后,PPARγ激活导致G1期细胞周期停滞。

结论

结肠癌细胞中PPARγ途径的激活具有强大的抗增殖作用,表明这种核激素受体可能为人类结直肠癌的预防和治疗提供一个新靶点。

相似文献

1
Activation of PPARgamma leads to inhibition of anchorage-independent growth of human colorectal cancer cells.过氧化物酶体增殖物激活受体γ(PPARγ)的激活导致人结肠癌细胞非锚定依赖性生长受到抑制。
Gastroenterology. 1998 Nov;115(5):1049-55. doi: 10.1016/s0016-5085(98)70072-1.
2
Activation of peroxisome proliferator-activated receptor gamma by troglitazone inhibits cell growth through the increase of p27KiP1 in human. Pancreatic carcinoma cells.曲格列酮激活过氧化物酶体增殖物激活受体γ通过增加人胰腺癌细胞中p27KiP1来抑制细胞生长。
Cancer Res. 2000 Oct 1;60(19):5558-64.
3
Activation of peroxisome proliferator-activated receptor gamma inhibits cell growth via apoptosis and arrest of the cell cycle in human colorectal cancer.过氧化物酶体增殖物激活受体γ的激活通过诱导细胞凋亡和使细胞周期停滞来抑制人结直肠癌细胞的生长。
J Dig Dis. 2007 May;8(2):82-8. doi: 10.1111/j.1443-9573.2007.00290.x.
4
Thiazolidinediones inhibit growth of gastrointestinal, biliary, and pancreatic adenocarcinoma cells through activation of the peroxisome proliferator-activated receptor gamma/retinoid X receptor alpha pathway.噻唑烷二酮类药物通过激活过氧化物酶体增殖物激活受体γ/视黄酸X受体α通路来抑制胃肠道、胆管和胰腺腺癌细胞的生长。
Exp Cell Res. 2003 Sep 10;289(1):143-51. doi: 10.1016/s0014-4827(03)00263-5.
5
A non-thiazolidinedione partial peroxisome proliferator-activated receptor gamma ligand inhibits vascular smooth muscle cell growth.一种非噻唑烷二酮类过氧化物酶体增殖物激活受体γ部分激动剂可抑制血管平滑肌细胞生长。
Eur J Pharmacol. 2003 Apr 18;466(3):225-34. doi: 10.1016/s0014-2999(03)01556-5.
6
Magnitude of peroxisome proliferator-activated receptor-gamma activation is associated with important and seemingly opposite biological responses in breast cancer cells.过氧化物酶体增殖物激活受体γ激活的程度与乳腺癌细胞中重要且看似相反的生物学反应相关。
J Investig Med. 2001 Sep;49(5):413-20. doi: 10.2310/6650.2001.33786.
7
Activation of peroxisome proliferator-activated receptor gamma inhibits the growth of human pancreatic cancer.过氧化物酶体增殖物激活受体γ的激活抑制人胰腺癌的生长。
Pathobiology. 2001;69(5):258-65. doi: 10.1159/000064336.
8
Regulation of the growth arrest and DNA damage-inducible gene 45 (GADD45) by peroxisome proliferator-activated receptor gamma in vascular smooth muscle cells.过氧化物酶体增殖物激活受体γ对血管平滑肌细胞中生长停滞和DNA损伤诱导基因45(GADD45)的调控
Circ Res. 2003 Aug 22;93(4):e38-47. doi: 10.1161/01.RES.0000088344.15288.E6. Epub 2003 Jul 24.
9
Ligands for peroxisome proliferator-activated receptor gamma inhibit growth and induce apoptosis of human papillary thyroid carcinoma cells.过氧化物酶体增殖物激活受体γ的配体可抑制人甲状腺乳头状癌细胞的生长并诱导其凋亡。
J Clin Endocrinol Metab. 2001 May;86(5):2170-7. doi: 10.1210/jcem.86.5.7493.
10
Peroxisome proliferator-activated receptor gamma ligand troglitazone induces cell cycle arrest and apoptosis of hepatocellular carcinoma cell lines.过氧化物酶体增殖物激活受体γ配体曲格列酮诱导肝癌细胞系的细胞周期停滞和凋亡。
Cancer. 2002 Nov 15;95(10):2243-51. doi: 10.1002/cncr.10906.

引用本文的文献

1
NSAID-encapsulated nanoparticles as a targeted therapeutic platform for modulating chronic inflammation and inhibiting cancer progression: a review.非甾体抗炎药包裹的纳米颗粒作为调节慢性炎症和抑制癌症进展的靶向治疗平台:综述
Inflammopharmacology. 2025 Apr 26. doi: 10.1007/s10787-025-01760-8.
2
Turkish coffee has an antitumor effect on breast cancer cells in vitro and in vivo.土耳其咖啡在体外和体内对乳腺癌细胞均具有抗肿瘤作用。
Nutr Metab (Lond). 2024 Sep 13;21(1):73. doi: 10.1186/s12986-024-00846-4.
3
Efficient Synthesis for Altering Side Chain Length on Cannabinoid Molecules and Their Effects in Chemotherapy and Chemotherapeutic Induced Neuropathic Pain.
高效合成大麻素分子侧链长度改变物及其在化疗和化疗诱导性神经痛中的作用。
Biomolecules. 2022 Dec 13;12(12):1869. doi: 10.3390/biom12121869.
4
Peroxisome Proliferator-Activated Receptors and the Hallmarks of Cancer.过氧化物酶体增殖物激活受体与癌症的特征。
Cells. 2022 Aug 5;11(15):2432. doi: 10.3390/cells11152432.
5
NSAIDs and Cancer Resolution: New Paradigms beyond Cyclooxygenase.非甾体抗炎药与癌症消退:超越环氧化酶的新范式。
Int J Mol Sci. 2022 Jan 27;23(3):1432. doi: 10.3390/ijms23031432.
6
Falcarindiol Purified From Carrots Leads to Elevated Levels of Lipid Droplets and Upregulation of Peroxisome Proliferator-Activated Receptor-γ Gene Expression in Cellular Models.从胡萝卜中提纯的镰叶芹二醇导致细胞模型中脂滴水平升高及过氧化物酶体增殖物激活受体γ基因表达上调。
Front Pharmacol. 2020 Aug 28;11:565524. doi: 10.3389/fphar.2020.565524. eCollection 2020.
7
Peroxisome Proliferator-Activated Receptors: Experimental Targeting for the Treatment of Inflammatory Bowel Diseases.过氧化物酶体增殖物激活受体:炎症性肠病治疗的实验性靶点
Front Pharmacol. 2020 May 27;11:730. doi: 10.3389/fphar.2020.00730. eCollection 2020.
8
The anticancer effects and mechanisms of fucoxanthin combined with other drugs.岩藻黄质与其他药物联合的抗癌作用及其机制。
J Cancer Res Clin Oncol. 2019 Feb;145(2):293-301. doi: 10.1007/s00432-019-02841-2. Epub 2019 Jan 9.
9
Expression of CD133 in endometrial cancer cells and its implications.CD133在子宫内膜癌细胞中的表达及其意义。
J Cancer. 2017 Jul 15;8(11):2142-2153. doi: 10.7150/jca.18869. eCollection 2017.
10
Escape of U251 glioma cells from temozolomide-induced senescence was modulated by CDK1/survivin signaling.U251胶质瘤细胞从替莫唑胺诱导的衰老中逃逸受CDK1/生存素信号传导调控。
Am J Transl Res. 2017 May 15;9(5):2163-2180. eCollection 2017.